Biscayne Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Biscayne Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013159
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biscayne Pharmaceuticals Inc (Biscayne) is a clinical stage biotechnology company that conducts research and development services. The company conducts research and development of therapies based on growth hormone-releasing hormone analogs. Its technology concentrates on a platform of synthetic peptides that are variants of GHRH. Biscayne’s compounds include GHRH antagonists and GHRH agonists. The company’s products find application in the therapeutic areas of cancer, including castrate-resistant prostate cancer, and for the repair of cardiac damage in heart disease patients. It provides treatment for cardiac damage resulting from heart attacks and other cardiovascular disorders. Biscayne is headquartered in Miami, Florida, the US.

Biscayne Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Biscayne Pharma Raises USD3.4 Million in Venture Financing 10
Biscayne Pharma Raises US$2.6 Million In Venture Financing 11
Biscayne Pharma Raises Funds through Seed Financing 12
Biscayne Pharma Raises US$1.5 Million In Venture Financing 13
Merger 14
Biscayne Pharma Merges with Insero Health 14
Licensing Agreements 15
Biscayne Pharma Enters Into Licensing Agreement With University Of Miami 15
Biscayne Pharmaceuticals Inc – Key Competitors 16
Biscayne Pharmaceuticals Inc – Key Employees 17
Biscayne Pharmaceuticals Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
10/24/2016: Newly Published Data Show Biscayne Pharmaceuticals’ Novel Antiepileptic Drug Can Eliminate Seizures In Models Of Dravet Syndrome 19
Clinical Trials 20
May 09, 2017: Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug Designation for Dravet Syndrome 20
Jun 28, 2016: Biscayne Pharmaceuticals Presents Data On Novel Antiepileptic Agent BIS-001 AT EILAT Conference On New Antiepileptic Drugs 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biscayne Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Biscayne Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biscayne Pharma Raises USD3.4 Million in Venture Financing 10
Biscayne Pharma Raises US$2.6 Million In Venture Financing 11
Biscayne Pharma Raises Funds through Seed Financing 12
Biscayne Pharma Raises US$1.5 Million In Venture Financing 13
Biscayne Pharma Merges with Insero Health 14
Biscayne Pharma Enters Into Licensing Agreement With University Of Miami 15
Biscayne Pharmaceuticals Inc, Key Competitors 16
Biscayne Pharmaceuticals Inc, Key Employees 17

★海外企業調査レポート[Biscayne Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Macerich Co:企業のM&A・事業提携・投資動向
    The Macerich Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Macerich Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Kinder Morgan Inc (KMI):石油・ガス:M&Aディール及び事業提携情報
    Summary Kinder Morgan Inc (KMI) is a midstream energy infrastructure company that owns and operates through a network of pipelines and terminals. Its pipelines transport natural gas, crude oil, gasoline, condensate, refined petroleum products and other products, and its terminals transload and store …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • DIAsource ImmunoAssays SA:企業の製品パイプライン分析2018
    Summary DIAsource ImmunoAssays SA (DIAsource), formerly BioSource Europe SA, a subsidiary of BioVendor - Laboratorni Medicina as, is a diagnostics company that develops, manufactures and markets clinical diagnostic products. The company’s products comprise immunoassays, antibodies, instruments and R …
  • Public Joint-Stock Company Commercial Bank Privatbank:企業の戦略・SWOT・財務分析
    Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • ZTE Corporation:企業のM&A・事業提携・投資動向
    ZTE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ZTE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Zhifei Biological Products Co Ltd (Zhifei) is a vaccine manufacturer. The company offers HibACon, MeningACon, menwayc, mycobacterium vaccae, haemophilus influenzae type b conjugate vaccine and hepatitis A (live) vaccine, freeze-dried. It research, develops, produces and markets vac …
  • U-Haul International Inc:企業の戦略的SWOT分析
    U-Haul International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • IRPC Public Company Limited:企業の戦略・SWOT・財務情報
    IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Immunocore Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Immunocore Ltd (Immunocore) is a biotechnology company that focuses on the development of immunotherapeutic drugs for the treatment of cancer, infectious diseases and autoimmune diseases. The company develops its drugs using its proprietary T cell receptor (TCR) technology. Its products unde …
  • Bank of China Ltd:企業のM&A・事業提携・投資動向
    Bank of China Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of China Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Brunei LNG Sdn Bhd:企業の戦略的SWOT分析
    Brunei LNG Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Emcure Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures and markets a range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. It also manufactures active pharmaceutical ingredients (APIs) primarily f …
  • Agro Tech Foods Limited:企業の戦略・SWOT・財務情報
    Agro Tech Foods Limited - Strategy, SWOT and Corporate Finance Report Summary Agro Tech Foods Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zogenix Inc (ZGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Zogenix Inc (Zogenix) is a pharmaceutical company with focus on central nervous system (CNS) disorders. It develops and commercializes therapies for rare CNS disorders. The company’s lead product candidate ZX008 (low dose fenfluramine) is intended for the treatment of Dravet syndrome and Len …
  • The Hub Power Co Ltd:発電所・企業SWOT分析
    The Hub Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Praxair Inc (PX)-エネルギー分野:企業M&A・提携分析
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company offers atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and builds …
  • SGS SA (SGSN):医療機器:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • A&D Company Ltd (7745):企業の財務・戦略的SWOT分析
    Summary A&D Company Ltd (A&D Company) is a medical equipment company that manufactures, designs, develops, and distributes advanced measuring, controlling, monitoring, and testing instruments. The company’s products include powertrain testing systems, digital analog converter, DSP platform, model ba …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆